Carrier says she was “terrified” that the antibiotics would one day stop working for her. “UTIs were one of the worst things I’ve been through,” she adds. Liz S. also struggles with ...

The US Food and Drug Administration has approved a new type of antibiotic to treat urinary tract infections. The pill, gepotidacin, will be sold under the brand name Blujepa and is expected to be ...

The Food and Drug Administration on Tuesday approved the first drug in a new class of antibiotics for treating urinary tract infections — the first time that’s happened in nearly 30 years.

As cases of urinary tract infections grow, infections are also getting harder to treat with commonly used antibiotics. Contaminated meat, especially poultry, can spread E. coli bacteria that cause ...

Urinary tract infections (UTIs) are among the most common bacterial infections, affecting millions worldwide. However, the increasing resistance of bacteria to standard antibiotics has made ...

On March 25, the U.S. Food and Drug Administration (FDA) approved the first new antibiotic to treat UTIs in 30 years. The medication, gepotidacin, targets E. coli bacteria, which is responsible ...

Gonorrhoea is resistant to nearly all antibiotics, but one commonly used for urinary tract infections (UTIs) may be able to treat drug-resistant cases. The sexually transmitted infection (STI ...

Blujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial treatment option for drug-resistant urinary tract infections (UTIs). In clinical trials ...

For millions of women, urinary tract infections (UTIs) are more than just a minor health nuisance – they are a recurring, disruptive burden. With rising antibiotic resistance making standard ...